Please assess the completion status of the following clinical trial:

Trial Title: Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of biliary atresia or primary sclerosing cholangitis.~* Clinical controls who are undergoing upper endoscopy or colonoscopy and do not have biliary atresia or primary sclerosing cholangitis.~* Subjects who have been on oral vancomycin for 1 year for biliary atresia or -~Exclusion Criteria:~* Patients that have taken antibiotics within the last 3 month will be excluded as this will alter the original bacterial flora.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 20 Years
- Healthy Volunteers: f

Study Arms:
- Oral Vancomycin (Type: EXPERIMENTAL): Vancocin

Based on this trial design, predict the completion outcome and termination type (if applicable).